- All sections
- A - Human necessities
- A61P - Specific therapeutic activity of chemical compounds or medicinal preparations
- A61P 7/06 - Antianaemics
Patent holdings for IPC class A61P 7/06
Total number of patents in this class: 1707
10-year publication summary
|
59
|
60
|
114
|
102
|
131
|
159
|
181
|
131
|
132
|
10
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Acceleron Pharma Inc. | 373 |
46 |
| Agios Pharmaceuticals, Inc | 211 |
33 |
| Daiichi Sankyo Company, Limited | 1863 |
31 |
| Global Blood Therapeutics, Inc. | 180 |
25 |
| Vifor (International) AG | 147 |
21 |
| Children's Medical Center Corporation | 1824 |
16 |
| The Children's Hospital of Philadelphia | 752 |
15 |
| FibroGen, Inc. | 164 |
14 |
| Takeda Pharmaceutical Company Limited | 2945 |
13 |
| Akebia Therapeutics, Inc. | 117 |
13 |
| Pharmacosmos Holding A/S | 185 |
13 |
| Epizyme, Inc. | 386 |
12 |
| Institut National de La Sante et de La Recherche Medicale (inserm) | 2608 |
12 |
| Keros Therapeutics, Inc. | 61 |
12 |
| Université Paris Cité | 703 |
12 |
| Novartis AG | 11276 |
11 |
| Amgen Inc. | 3900 |
11 |
| Sunshine Lake Pharma Co., Ltd. | 570 |
11 |
| The Regents of the University of California | 19503 |
10 |
| Assistance Publique-hopitaux de Paris (aphp) | 466 |
10 |
| Other owners | 1366 |